Tumor antigenicity affects the DNA immune response in TME, which is a key factor affecting the dependence on STING to induce indoleamine 2,3-dioxygenase (IDO) and promote Lewis lung cancer (LLC) growth. The gene discussed is IDO1; the disease is neoplasm.